Direxion Daily S&p Biotech Bear 3x Shares logo

Direxion Daily S&p Biotech Bear 3x Shares (LABD) Technical Analysis

$19.32-7.2%

Insights

  • Direxion Daily S&p Biotech Bear 3x Shares is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Direxion Daily S&p Biotech Bear 3x Shares stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Direxion Daily S&p Biotech Bear 3x Shares stock is in a downtrend↘️
  • Based on analysis of the Pivot Points, the current market trend for Direxion Daily S&p Biotech Bear 3x Shares stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
36.36
Neutral
Stochastic
25.17, 50.11
Neutral
Ultimate Oscillator
47.2
Neutral
Stochastic Relative Strength Index
82.28, 92.18
Sell
Moving Average Convergence Divergence
-1.69, -2.11
Neutral

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
21.53
Sell
20
21.93
Sell
50
26.81
Sell

Exponential Moving Average

Period (Days)

Value

Action

10
21.75
Sell
20
22.71
Sell
50
27.87
Sell

Volume Weighted Moving Average

Period (Days)

Value

Action

10
21.45
Sell
20
22.14
Sell
50
26.39
Sell

Double Exponential Moving Average

Period (Days)

Value

Action

10
21.29
Buy
20
20.26
Buy
50
18.57
Sell

Triple Exponential Moving Average

Period (Days)

Value

Action

10
21.77
Buy
20
21.16
Buy
50
18.47
Buy

Pivot

Pivot

Value

Resistance L3
24.64
Resistance L2
23.82
Resistance L1
23.28
Pivot Point
22.46
Support L1
21.92
Support L2
21.1
Support L3
20.56

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.